Filter News
Area of Research
- (-) National Security (17)
- (-) Neutron Science (14)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (36)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (15)
- Materials for Computing (2)
- Nuclear Science and Technology (4)
- Supercomputing (28)
News Type
News Topics
- (-) Biomedical (11)
- (-) Clean Water (2)
- (-) Grid (4)
- (-) Machine Learning (15)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (1)
- Artificial Intelligence (17)
- Big Data (6)
- Bioenergy (8)
- Biology (9)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (3)
- Climate Change (5)
- Composites (1)
- Computer Science (29)
- Coronavirus (9)
- Cybersecurity (17)
- Decarbonization (4)
- Energy Storage (5)
- Environment (10)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (2)
- Fusion (2)
- High-Performance Computing (6)
- Materials (13)
- Materials Science (21)
- Mathematics (1)
- Microscopy (2)
- Nanotechnology (9)
- National Security (33)
- Neutron Science (73)
- Nuclear Energy (5)
- Partnerships (4)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (6)
- Security (11)
- Simulation (1)
- Summit (6)
- Sustainable Energy (3)
- Transportation (4)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.